Source: Atherosclerosis. Unidades: FCF, FM
Subjects: DOENÇAS CARDIOVASCULARES, CARDIOLOGIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPÓSITO, Andrei Carvalho et al. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, v. 166, n. 2, p. 311-321, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(02)00334-9. Acesso em: 08 nov. 2024.APA
Spósito, A. C., Santos, R. D., Amâncio, R. F., Ramires, J. A. F., Chapman, M. J., & Maranhão, R. C. (2003). Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, 166( 2), 311-321. doi:10.1016/s0021-9150(02)00334-9NLM
Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9Vancouver
Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9